Advertisement

Topics

Magellan Rx Management CEO Mostafa Kamal Named to Shatterproof’s Substance Use Disorder Treatment Task Force

14:45 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Magellan Health endorses National Principles of Care Magellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan Rx Management, has been named to the Substance Use Diso...

Other Sources for this Article

Magellan Health, Inc.
Media Contact:
Colleen Flanagan Johnson, 860-507-1923
cefjohnson@magellanhealth.com
or
Investor Contact:
Joe Bogdan, 860-507-1910
jbogdan@magellanhealth.com

NEXT ARTICLE

More From BioPortfolio on "Magellan Rx Management CEO Mostafa Kamal Named to Shatterproof’s Substance Use Disorder Treatment Task Force"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...